Not Yet RecruitingNot Applicable

Chronic Total Occlusion and Triglyceride-Glucose Index

Turkey (Türkiye)200 participantsStarted 2026-03-15

Plain-language summary

We retrospectively analyzed 200 CAD patients undergoing coronary angiography between 2026-2027. Patients were grouped by CTO presence. Clinical and laboratory parameters were compared, and logistic regression was performed to identify independent predictors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults ≥18 years of age, patients undergoing coronary angiography, non-obese individuals Exclusion Criteria: * Patients \<18 years of age, history of atrial fibrillation, pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease, obesity (BMI \>30 kg/m²), inaccessible patient records

What they're measuring

The primary outcome measure will be the difference in the triglyceride-glucose (TyG) index between patients with chronic total occlusion (CTO) and those without CTO, assessed from routinely obtained blood samples.

Timeframe: 1 Year

Trial details

NCT IDNCT07451860

SponsorKırıkkale University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-07-15

Contact for this trial

RUKİYE GÖNEN ÖZDEMİR

+905054503953 rukiye_gonen@hotmail.com

View on ClinicalTrials.gov More CAD - Coronary Artery Disease trials